Clinical Trial Update: Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis [Phase 2, Phase 3]

View source ↗

Summary

This entry notes a completed Phase 2/3 clinical trial comparing mycophenolate mofetil with cyclophosphamide in ANCA-associated vasculitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Vasculitis | Phase 2, Phase 3 | Status: COMPLETED